Cytosorbents announces $6.25 million stock financing and Avenue Capital credit facility restructuring
CTSO•Cytosorbents announced a $6.25 million common stock financing priced at-the-market under Nasdaq rules, alongside a restructuring of its Avenue Capital credit facility.
1. Financing and restructuring
Cytosorbents announced a $6.25 million common stock financing priced at-the-market under Nasdaq rules and a concurrent restructuring of its Avenue Capital credit facility.




